Cardiac Insight

16 articles about Cardiac Insight

• Cardiac Insight’s Cardea SOLO™ Wearable ECG System Chosen for Stanford Medicine Study to Measure Atrial Fibrillation in Older Women

  1/5/2023

  Cardiac Insight, Inc. announced that researchers at Stanford Medicine selected the company’s Cardea SOLO™ wearable ECG system for a medical study entitled: Serial 7-Day Electrocardiogram Patch Screening for Atrial Fibrillation in High-Risk Older Women by the CHARGE-AF Score The study set out to measure asymptomatic atrial fibrillation in older women since AF is associated with an increased risk of stroke.

• Cardiac Insight Comments on CMS Announcement of National Payment Rates for Long-Term Continuous ECG (LT-ECG) Monitoring in 2023

  11/4/2022

  Cardiac Insight, Inc., creators of Cardea SOLO™ prescription cardiac sensors and automated electrocardiography Analysis Software, shares its perspective on the latest CMS ruling, which provides nationwide physician confidence in receiving the appropriate reimbursement for prescribing LT-ECG ambulatory diagnostic testing.

• Cardiac Insight’s Cardea SOLO™ ECG System Named as Finalist in Fierce Innovation Awards Healthcare Edition

  10/24/2022

  Cardiac Insight, Inc., a leading healthcare innovator specializing in prescription-based wearable cardiac sensors and automated electrocardiogram (ECG) analysis software for cardiac arrhythmia diagnosis, has been named a finalist in the 2022 Fierce Healthcare Innovation Awards for its Cardea SOLO™ ECG System.

• Cardiac Insight Comments on CMS Plans to Establish Nationwide Payment for Long-Term ECG Monitoring in 2023

  7/12/2022

  Cardiac Insight, Inc., a leading healthcare innovator specializing in prescription-based wearable cardiac sensors and automated electrocardiogram analysis software for cardiac arrhythmia diagnosis, shares its perspective on recent announcements impacting its served markets.

• Cardiac Insight Awarded Wearable Medical Devices and Mobile Medical Applications Category Group Purchasing Agreement with Premier

  6/7/2021

  Cardiac Insight, Inc. (“Cardiac Insight” or the “Company) is a healthcare innovator specializing in wearable cardiac sensors and proprietary software that automatically analyzes electrocardiogram (ECG) data to detect arrythmias, including atrial fibrillation

• Cardiac Insight Announces Expansion Into More Than 20 Asia-Pacific Markets with i.SigNal by Dreamtech Partnership

  6/3/2021

  Dreamtech distributes Cardea SOLO™ ECG System in Korea through its new healthcare organization iSigNal, and lead commercial expansion in 20+ other APAC countries.

• Cardiac Insight Comments on Medicare Administrative Contractor Novitas Rate Publication

  2/1/2021

  Decision to slash reimbursement rates limits patient and physician access to innovative ECG technologies proven to yield earlier detection and diagnosis of dangerous abnormal heart rhythms that disproportionately affect seniors

• Cardiac Insight Continues Record Growth and Expands Executive Leadership Team in 2020

  12/21/2020

  LeAnn Affholter, Vice President of People, and Carla Pagotto, Vice President of Marketing, join Cardiac Insight’s team to support growth and accelerate market adoption

• Cardiac Insight, Inc. Partners with VivoSense® (Vivonoetics, Inc.) to Expand the Use of Its Wearable Cardiac Sensors in Regulated Pharmaceutical Clinical Trials and Other Healthcare Research Applications

  11/1/2018

  Partnership to Provide Advanced Insights Into Performance of New Medicines and Therapies

• Cardiac Insight’s Wearable ECG Sensor, Cardea SOLO™, Continues to Attract Premier Cardiology Groups Across the U.S.; Announces Baltimore Heart Associates and Regional Cardiac Arrhythmia as Customers

  9/6/2018

  Company Experiencing Steady Sales Growth and Strong Repeat Orders from Existing Customers

• Cardiac Insight, Inc. to Showcase Industry-First Cardiac Devices for Atrial Fibrillation and Sudden Cardiac Arrest Risk Detection at Heart Rhythm 2018, Heart Rhythm Society’s 39th Annual Scientific Sessions, May 9-11, Exhibit 1071

  5/3/2018

  Cardiac Insight, Inc. announced the company will showcase its innovative solutions for the first time at Heart Rhythm Society’s 39th Annual Scientific Sessions.

• Cardiac Insight Secures First Cardiology Customers for Its Wearable ECG Sensor, Cardea SOLO™

  11/15/2017

  Early physician and patient experiences with Cardea SOLO are confirming the FDA-cleared cardiac device, designed to streamline arrhythmia detection in patients, is providing a higher standard of ambulatory cardiac care and efficiencies in cardiac practices.

• Cardiac Insight Continues Steady Beat Of Progress With New $4.5 Million Investment And Attracts Prestigious Healthcare M&A Executive, Clifford J. Stocks, To Its Board Of Directors

  9/6/2017

• Cardiac Insight’s "Cardea SOLO" Supports Top Arrhythmia Experts’ Acknowledgement: Wearable Cardiac Monitors Are Effective For Tracking Atrial Fibrillation Following Cardiac Ablation

  7/11/2017

• Cardiac Insight Acquires Cardea Associates To Bring Forth New Standard Of Care For Cardiac Screening In Young Athletes

  10/1/2015

• Cardiac Insight Raises $7 Million

  7/10/2014